BackOrchard Therapeutics plc Overview

Orchard Therapeutics plc Net Income

Profitability analysis for ORTX.

Quarterly Net Income

-$35.32M
25.75% YoY

As of Sep 2023

Annual Net Income (TTM)

$69.86M
139% YoY

Trailing 12 months ending Sep 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...